SCHEMBL8095025

SCHEMBL8095025

CC(C)S(=O)(=O)NC(=O)Nc1ccc(Br)cc1.[NaH]

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FPR2 P25090 7/20 0.55
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
RAB9A P51151 3/20 0.53
POLB P06746 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
LMNA P02545 1/20 0.53
CA1 P00915 4/20 0.51
CA2 P00918 4/20 0.51
CA9 Q16790 4/20 0.51
CA12 O43570 3/20 0.51
NPC1 O15118 2/20 0.50
CYP2C9 P11712 1/20 0.50
MAOA P21397 1/20 0.50
MAOB P27338 1/20 0.50
FPR1 P21462 1/20 0.49
CNR1 P21554 1/20 0.49
TSHR P16473 1/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8083324 0.98 FPR2 (0.56) FPR2MEN1KMT2ARAB9APOLB
SCHEMBL8083304 0.84 ALDH1A1 (0.54) MEN1KMT2ARAB9APOLBSMN1; SMN2
SCHEMBL8091318 0.84 TP53 (0.56) MEN1KMT2ARAB9ASMN1; SMN2CA1
SCHEMBL8095018 0.83 RAB9A (0.60) FPR2MEN1KMT2ARAB9APOLB
SCHEMBL8091346 0.82 ALDH1A1 (0.56) MEN1KMT2ARAB9APOLBSMN1; SMN2
SCHEMBL8663690 0.81 ACP1 (0.62) KMT2ARAB9APOLBSMN1; SMN2LMNA
SCHEMBL6463101 0.81 SAE1 (0.51) MEN1KMT2APOLBSMN1; SMN2LMNA
SCHEMBL8083369 0.77 MEN1 (0.59) MEN1KMT2ARAB9APOLBSMN1; SMN2
SCHEMBL8083234 0.75 EPHX1 (0.62) MEN1KMT2ARAB9APOLBLMNA
SCHEMBL9487965 0.75 CA1 (0.65) MEN1KMT2ARAB9APOLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6147115-A SULFONYLUREIDO-4-HALOBENZENE DERIVATIVES; ANTICARCINOGENIC AGENTS ELI LILLY AND COMPANY (US) 2000-11-14 US disclosed
EP-0467621-B1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them LILLY CO ELI (US) 1994-06-15 EP disclosed
US-5216026-A Administering to the mammal N-1-butanesulfonamide derivatives and salts ELI LILLY AND COMPANY (US) 1993-06-01 US disclosed
EP-0467621-A1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them ELI LILLY AND COMPANY (US) 1992-01-22 EP disclosed